Literature DB >> 32710944

Circular RNAs: Regulatory functions in respiratory tract cancers.

Ziyi Peng1, Shuai Fang2, Meina Jiang2, Xiaodong Zhao3, Chengwei Zhou4, Zhaohui Gong5.   

Abstract

Circular RNAs (circRNAs) are a class of single-stranded RNAs having a covalently closed loop structure generated from back-splicing of pre-mRNA. These novel RNAs are characterized by high stability, abundance and conservation. Accumulating evidence has revealed that circRNAs are intimately associated with the pathogenesis, development and progression of multiple human diseases, including respiratory tract cancers. CircRNAs may serve as oncogenes or tumor suppressors to influence cell proliferation, differentiation, apoptosis, invasion and metastasis. CircRNAs may act as microRNA (miRNA) sponges, interact with RNA-binding proteins (RBPs), regulate gene transcription and/or translate into mini-peptides or proteins. In this review, we discuss recent progress in understanding the pathologic roles of circRNAs in respiratory tract cancers, such as nasopharyngeal carcinoma, laryngeal squamous cell carcinoma, and especially lung adenocarcinoma. We further discuss the diagnostic, therapeutic and prognostic roles as potential biomarkers in respiratory tract cancers, providing insight into the possibilities of applying circRNAs as therapeutic targets and biomarkers in precision oncology.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biomarker; Circular RNA; MicroRNA sponge; RNA-binding protein; Respiratory tract cancer

Mesh:

Substances:

Year:  2020        PMID: 32710944     DOI: 10.1016/j.cca.2020.07.042

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  2 in total

Review 1.  Circular RNAs in hepatocellular carcinoma: Recent advances.

Authors:  Zhao-Shan Niu; Wen-Hong Wang
Journal:  World J Gastrointest Oncol       Date:  2022-06-15

2.  circ_0000567/miR-421/TMEM100 Axis Promotes the Migration and Invasion of Lung Adenocarcinoma and Is Associated with Prognosis.

Authors:  Yang Hong; Jiahui Si; Bufan Xiao; Ying Xiong; Chenyue Dai; Yue Yang; Shaolei Li; Yuanyuan Ma
Journal:  J Cancer       Date:  2022-02-28       Impact factor: 4.207

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.